DOH Central Pharmacy

Form 483 issued July 28, 2025 · Tallahassee, Florida

Inspection
Jul 9 – Jul 28, 2025
Investigator
Dorothy P. Kramer
Observations
6
Pages
7
FEI number
1036356

In short: On July 28, 2025, FDA issued a Form 483 with 6 observations to DOH Central Pharmacy in Tallahassee, Florida (FEI 1036356) after an inspection that ran Jul 9 – Jul 28, 2025. The investigator was Dorothy P. Kramer. Most observations concern quality system and packaging & labeling.

At a glance

Quality system and packaging & labeling account for 4 of 6 observations.

Quality system3
Packaging & labeling1
Laboratory controls1
Materials1

What FDA observed

Preview: the opening words of each observation
  1. 01

    The responsibilities and procedures applicable to the quality control unit…

  2. 02

    Written records of major equipment cleaning and use are not included…

  3. 03

    Drug products do not bear an expiration date determined by appropriate stability data to assure they…

  4. 04

    Reserve drug product samples are not representative of each kit or batch of drug product and…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at DOH Central Pharmacy?

FDA listed 6 observations on this Form 483, mostly about quality system, packaging & labeling and laboratory controls. The opening words of each observation are shown on this page.

Who inspected DOH Central Pharmacy?

Dorothy P. Kramer is named on this Form 483, for the inspection of Jul 9 – Jul 28, 2025. Each investigator has a profile showing what they cite most.

When was DOH Central Pharmacy inspected by FDA?

The inspection ran Jul 9 – Jul 28, 2025, and the Form 483 is dated July 28, 2025.

How do I get the full Form 483 for DOH Central Pharmacy?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free